2m 2m 2m 2m 2m 2m 2m
IMPACT BIO (IBO)
NYSE
$3.73-$0.07 (-1.97%)
Price as of Oct 22, 2026 7:30 PM EDT- $34.3MMarket Cap
- -45.23%1-Year Change
- BiotechnologyIndustry
IMPACT BIO (IBO)
$3.73-$0.07 (-1.97%)
IBO | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $3.80 | ||
Change | +$0.75 (+23.03%) | ||
Open | $3.82 | ||
High | $4.23 | ||
Low | $3.60 | ||
Previous Close | $4.02 | ||
Volume | 21,552 | ||
30-Day Average Volume | 15,899 | ||
1-Week Change | 18.12% | ||
1-Month Change | -42.68% | ||
1-Year Change | -45.23% | ||
3-Year Change | N/A | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 8.5M | ||
Total Assets | $16.7M | ||
Market Cap | $34.3M | ||
Enterprise Value | $71.7M | ||
Period: QTR TTM FY | |||
Revenue | $3,000.00 | ||
Net Income | -$699,000.00 | ||
Free Cash Flow | $470,000.00 | ||
EBIT | -$699,000.00 | ||
EBITDA | -$415,000.00 | ||
Net Working Capital | -$1.7M | ||
EPS | -$0.13 | ||
Enterprise Value/EBITDA | -173 | ||
Enterprise Value/Revenue | 23,896 | ||
P/B | 3 | ||
P/E | -32 | ||
PEG | -1 | ||
Price/Free Cash Flow | 73 | ||
Price/Operating Cash Flow | 73 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 12.62 | ||
Last Split Date | 09/23/2026 | ||
Earnings & Revenue